|
⚲
|
| Keyboard |
| Robert Calcaterra | |
|---|---|
| Firm | |
| Address | 212 Third Avenue North Suite 352 Minneapolis, MN 55401 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Cardialen Inc | 021-318779 | Director | 16.1 M of 16.1 M |
||
| Cardialen Inc | 021-318777 | Director | 0.9 M of 1.0 M |
||
| Euclises Pharmaceuticals Inc | 021-248588 | Director | 1.2 M of 2.7 M |
||
| Cardialen Inc | 021-241452 | Director | 1.6 M of 2.0 M |
||
| Cardialen Inc | 021-209846 | Director | 2.5 M of 4.0 M |
||
| Euclises Pharmaceuticals Inc | 021-209852 | Director | 1.9 M of 1.9 M |
||
| Galera Therapeutics Inc | 021-188108 | Director | 11.0 M of 11.0 M |
||
| Euclises Pharmaceuticals Inc | 021-178452 | Director | 0.2 M of 0.4 M |
||
| Galera Therapeutics LLC | 021-157856 | Director | 0.4 M of 0.4 M |
||
| Cardialen Inc | 021-147885 | Executive Officer | 2.4 M | ||
| Galera Therapeutics LLC | 021-142534 | Director | 0.8 M of 0.8 M |
||